| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
 |
|
Site Navigation
| ALS News & Research For postings of news or research links and articles related to ALS |
advertisement
| Reply |
|
|
Thread Tools | Display Modes |
|
|
| ALS News & Research For postings of news or research links and articles related to ALS |
| Reply |
|
|
Thread Tools | Display Modes |
10-12-2019, 06:22 PM
|
#1 | |||
|
||||
|
Grand Magnate
|
Reldesemtiv May Reduce Functional Decline in Fast Progressing ALS, New Analysis Suggests
In Fast Advancing ALS, Reldesemtiv May Lower Functional Decline, Data Says Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis Finds Reldesemtiv in ALS Patients Slows Decline in Speech Muscle Control, Trial Data Show FORTITUDE-ALS study results suggest reldesemtiv may have efficaciousness in amyotrophic lateral sclerosis |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| FDA Approves Edaravone for ALS: Phase 3 Trial Finds It Slows Progression | ALS News & Research | |||
| FDA Approves Edaravone for ALS: Phase 3 Trial Finds It Slows Progression | ALS News & Research | |||
| MJFF Funds Continuing Analysis of Data from Phase 2 Trial of CERE-120 | Parkinson's Disease | |||
Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis
Linear Mode
